- Home
- ALLK vs STCN Comparison
ALLK vs STCN Comparison
Compare ALLK & STCN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ALLK
- STCN
- Stock Information
- Founded
- ALLK 2012
- STCN 1986
- Country
- ALLK United States
- STCN United States
- Employees
- ALLK N/A
- STCN N/A
- Industry
- ALLK Biotechnology: Pharmaceutical Preparations
- STCN Advertising
- Sector
- ALLK Health Care
- STCN Consumer Discretionary
- Exchange
- ALLK Nasdaq
- STCN Nasdaq
- Market Cap
- ALLK 58.0M
- STCN 63.4M
- IPO Year
- ALLK 2018
- STCN 1994
- Fundamental
- Price
- ALLK $1.16
- STCN $10.03
- Analyst Decision
- ALLK Hold
- STCN
- Analyst Count
- ALLK 5
- STCN 0
- Target Price
- ALLK $1.67
- STCN N/A
- AVG Volume (30 Days)
- ALLK 1.3M
- STCN 31.0K
- Earning Date
- ALLK 11-06-2024
- STCN 12-12-2024
- Dividend Yield
- ALLK N/A
- STCN N/A
- EPS Growth
- ALLK N/A
- STCN 166.76
- EPS
- ALLK N/A
- STCN 3.11
- Revenue
- ALLK N/A
- STCN $174,109,000.00
- Revenue This Year
- ALLK N/A
- STCN N/A
- Revenue Next Year
- ALLK N/A
- STCN N/A
- P/E Ratio
- ALLK N/A
- STCN $3.22
- Revenue Growth
- ALLK N/A
- STCN N/A
- 52 Week Low
- ALLK $0.54
- STCN $7.36
- 52 Week High
- ALLK $3.41
- STCN $13.00
- Technical
- Relative Strength Index (RSI)
- ALLK 51.18
- STCN 45.31
- Support Level
- ALLK $1.29
- STCN $9.66
- Resistance Level
- ALLK $1.56
- STCN $10.32
- Average True Range (ATR)
- ALLK 0.14
- STCN 0.61
- MACD
- ALLK -0.03
- STCN -0.02
- Stochastic Oscillator
- ALLK 14.89
- STCN 23.26
About ALLK Allakos Inc.
Allakos Inc is a clinical-stage company developing therapeutic antibodies that selectively target immunomodulatory receptors present on the surface of immune effector cells involved in allergic, inflammatory, and proliferative diseases. The company's lead program, AK006 targets Siglec-6, an inhibitory receptor expressed selectively on mast cells. Binding of AK006 to Siglec-6 is designed to activate the native inhibitory function of the receptor which in turn reduces mast cell activation.
About STCN Steel Connect Inc.
Steel Connect Inc is a diversified holding company. The company's operating segment include Direct Marketing and Supply Chain. It generates maximum revenue from the Direct Marketing segment. Geographically, it derives a majority of revenue from the United States and also has a presence in China; Netherlands, and others. The company serves clients in various industries including consumer electronics, communications, computing, software, storage, and retail industries.